Autopsy report · NCT00351039
Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer
Cause of deathSlow enrollment
“slow accrual”
Life of this trial
- Ran for about 2 years 2 months before it stopped.
- 8 participants enrolled.
- Results were posted on the registry 1 year 11 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Sponsor type
- University, hospital or other
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Bevacizumab; Erlotinib; Pemetrexed
- Participants
- 8
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.